MCRB - Seres Therapeutics Q2 2023 Earnings Preview
2023-08-07 15:44:27 ET
- Seres Therapeutics ( NASDAQ: MCRB ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open.
- The consensus EPS Estimate is $0.55 and the consensus Revenue Estimate is $125.67M.
- Over the last 1 year, MCRB has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 2 downward.
For further details see:
Seres Therapeutics Q2 2023 Earnings Preview